Fidaxomicin API Suppliers & Bulk Manufacturers
Available Forms: API (drug substance)
Available Strengths: Supplied to an in-house or pharmacopoeial specification
Reference Brands: Dificid, Dificlir
Category: Active Pharmaceutical Ingredient
Fidaxomicin is a narrow-spectrum macrocyclic antibiotic made by fermentation and used orally for Clostridioides difficile infection. It is sourced by formulators, CDMOs and R&D teams.
Manufacture or export Fidaxomicin API? List it or send an offer →
Product Description:
Fidaxomicin is a macrocyclic (macrolide-class) antibacterial produced by fermentation of the actinomycete Dactylosporangium aurantiacum. It inhibits bacterial RNA polymerase and acts mainly within the gut, with little absorbed into the bloodstream. In the US it is approved for C. difficile-associated diarrhoea in adults and children aged 6 months and older, and it is also approved in the EU for C. difficile infection (reference brands: Dificid, Dificlir).
Specification at a glance
| Traded form | Fermentation-derived 18-membered macrolactone glycoside; free compound, not a salt |
|---|---|
| CAS number | 873857-62-6 |
| Molecular formula | C52H74Cl2O18 |
| Molecular weight | 1058.0 g/mol |
| Pharmacopoeia | No USP monograph yet: USP's small-molecule priority list (April 2024) names fidaxomicin as a candidate for a new monograph. No Ph. Eur., JP, BP or IP monograph found (unverified). Supplied to an in-house specification. |
Regulatory files and timing
The FDA list of Drug Master Files (third quarter 2026) shows 6 active Type II API DMFs for this molecule. Few filings usually means few qualified sources, so early contact with suppliers pays off. For Europe, ask whether the supplier holds a CEP or an EU ASMF and, for imports into the EU, a written confirmation.
Generic or biosimilar entry. United States: Generics/biosimilars on the market (Jul 2025). European Union: No confirmed date.
Handling and quality points
As a fermentation product, fidaxomicin comes with a family of closely related natural analogues, so the specification needs limits for named related substances and a method that separates them. Ask about the producing strain, the purification steps and the solid form, as these shape the impurity and stability profile. The usual fermentation documentation applies, including residual solvents from extraction and TSE statements for any animal-derived raw materials.
Send an API enquiry All specialty APIs
Brand names are trademarks of their respective owners and identify the reference medicine only. Information is general and was checked in October 2026; confirm specifications and filings with the supplier before purchase.
Fidaxomicin API — third party manufacturing & bulk supply
Fidaxomicin API is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Fidaxomicin API is supplied as API (drug substance) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Fidaxomicin API listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Fidaxomicin API →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Ask for the GMP certificate, certificate of analysis and specification, together with a US DMF letter of access or EU ASMF for filing. Fermentation-specific items include the strain history, a TSE/BSE statement for raw materials and the related-substance profile. Stability data and a nitrosamine risk assessment are also normal requests.
Fermentation produces fidaxomicin alongside several structurally similar analogues, which are removed during purification. A good supplier will name the main related substances, set limits for each and use a validated HPLC method that separates them, with batch data showing consistency.
Yes. PharmaTradz introduces licensed manufacturers, CDMOs and research teams to GMP-compliant fidaxomicin producers, reviewing their documents before any contact. We only reveal your details once both sides agree.
Related Products
Monomethyl Auristatin E (MMAE) API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Adcetris, Padcev, Polivy, Tivdak
View DetailsNivolumab Drug Substance
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: Drug substance (bulk)
Reference Brands: Opdivo
View DetailsDabrafenib Mesylate API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Tafinlar, Finlee
View DetailsBenralizumab Drug Substance
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: Drug substance (bulk)
Reference Brands: Fasenra
View DetailsClotrimazole Granules or Pastes
Strength:
High-purity API
Form: Granules/ Paste
Reference Brands: -
View DetailsZinc Sulfate Powder
Strength:
Typically supplied as high-purity powder or crystals
Form: Powder/Granules or lumps
Reference Brands: -
View DetailsTalazoparib Tosylate API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Talzenna
View DetailsPlecanatide API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Trulance
View DetailsUsually answered within 48 hours | GMP documents shared before you commit